Chemical Composition and In Vitro Antidiabetic Effect of Extracts from Ripe, Unripe, and Fermented Unripe Cornus mas L. Fruits
Molecules · 2025
DOI: 10.3390/molecules30234625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Karolina Bernacka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fruit, Vegetable and Plant Nutraceutical Technology, Wrocław University of Environmental and Life Sciences, Chełmońskiego 37, 51-630 Wr…. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Plant Extracts, Fruit, Cornus. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wrocław University of Environmental and Life Sciences.
Abstract (Originalsprache)
This study aimed to investigate the chemical composition, antioxidant activity, and in vitro antidiabetic properties of extracts obtained from ripe, unripe, and fermented (unripe) cornelian cherry (Cornus mas L.) fruits. Polyphenols were identified using UPLC-ESI-qTOF-MS/MS and quantified by HPLC-PDA. Antioxidant activity was evaluated using ABTS, DPPH, and FRAP assays, while enzyme inhibitory activity was determined for α-glucosidase and α-amylase. Additionally, the effects of C. mas extracts on insulin sensitivity in adipocytes were investigated. The study’s results showed that each of the extracts tested contained varying proportions of substances with proven health-promoting properties. The extract from ripe fruits was characterized by the highest loganic acid content, whereas the extract from fermented unripe fruits contained a high amount of gallic acid, released through the hydrolysis of tannins during fermentation. The extract from unripe fruits exhibited the highest tannin content and the strongest antioxidant activity. All extracts inhibited α-glucosidase and α-amylase to a similar extent and improved insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting INSR or SLC2A4 expression. In conclusion, extracts from unripe and fermented C. mas fruits may represent promising agents for alleviating insulin resistance and preventing type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Fruit, Vegetable and Plant Nutraceutical Technology, Wrocław University of Environmental and Life Sciences, Chełmońskiego 37, 51-630 Wrocław, Poland.
- Institute of Fermentation Technology and Microbiology, Łódź University of Technology, Wólczańska 171/173, 90-530 Łódź, Poland.
- Department of Forensic Medicine, Division of Molecular Techniques, Wrocław Medical University, M. Skłodowskiej-Curie 52, 50-369 Wrocław, Poland.
- Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Faculty of Medicine, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
ORCID-Profile: Karolina Bernacka, Agata Czyżowska, Małgorzata Małodobra-Mazur, Monika Ołdakowska, Anna Otlewska, Tomasz Sozański, Alicja Z Kucharska
Förderung
- Wrocław University of Environmental and Life Sciences
Zitieren
APA
Bernacka, K., Czyżowska, A., Małodobra-Mazur, M., Ołdakowska, M., Otlewska, A., Sozański, T., & Kucharska, A. Z. (2025). Chemical Composition and In Vitro Antidiabetic Effect of Extracts from Ripe, Unripe, and Fermented Unripe Cornus mas L. Fruits. Molecules. https://doi.org/10.3390/molecules30234625
Vancouver
Bernacka K, Czyżowska A, Małodobra-Mazur M, Ołdakowska M, Otlewska A, Sozański T, et al. Chemical Composition and In Vitro Antidiabetic Effect of Extracts from Ripe, Unripe, and Fermented Unripe Cornus mas L. Fruits. Molecules. 2025. doi:10.3390/molecules30234625
BibTeX
@article{Bernacka2025,
author = {Bernacka, Karolina and Czyżowska, Agata and Małodobra-Mazur, Małgorzata and Ołdakowska, Monika and Otlewska, Anna and Sozański, Tomasz and Kucharska, Alicja Z},
title = {Chemical Composition and In Vitro Antidiabetic Effect of Extracts from Ripe, Unripe, and Fermented Unripe Cornus mas L. Fruits},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30234625}
}
EUVIMED